These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30977436)

  • 1. The use of mesenchymal stem cells for the treatment of progressive retinal diseases: a review.
    Borkowska-Kuczkowska A; Sługocka D; Świątkowska-Flis B; Boruczkowski D
    Regen Med; 2019 May; 14(4):321-329. PubMed ID: 30977436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications.
    Cislo-Pakuluk A; Marycz K
    Stem Cell Rev Rep; 2017 Oct; 13(5):598-602. PubMed ID: 28643176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional two-dimensional mesenchymal stem cells (MSCs) are better than spheroid MSCs on promoting retinal ganglion cells survival and axon regeneration.
    Huang W; Wang C; Xie L; Wang X; Zhang L; Chen C; Jiang B
    Exp Eye Res; 2019 Aug; 185():107699. PubMed ID: 31202832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases.
    Ding SLS; Kumar S; Mok PL
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials.
    Holan V; Palacka K; Hermankova B
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection of Transplanting Human Umbilical Cord Mesenchymal Stem Cells in a Microbead Induced Ocular Hypertension Rat Model.
    Ji S; Lin S; Chen J; Huang X; Wei CC; Li Z; Tang S
    Curr Eye Res; 2018 Jun; 43(6):810-820. PubMed ID: 29505314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal-Stem-Cell-Based Strategies for Retinal Diseases.
    Chen X; Jiang Y; Duan Y; Zhang X; Li X
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of retinal differentiation potential of mesenchymal stem cells: A promising approach for retinal cell therapy.
    Salehi H; Amirpour N; Razavi S; Esfandiari E; Zavar R
    Ann Anat; 2017 Mar; 210():52-63. PubMed ID: 27986614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells provide paracrine neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures.
    Labrador-Velandia S; Alonso-Alonso ML; Di Lauro S; García-Gutierrez MT; Srivastava GK; Pastor JC; Fernandez-Bueno I
    Exp Eye Res; 2019 Aug; 185():107671. PubMed ID: 31108056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration.
    Inoue Y; Iriyama A; Ueno S; Takahashi H; Kondo M; Tamaki Y; Araie M; Yanagi Y
    Exp Eye Res; 2007 Aug; 85(2):234-41. PubMed ID: 17570362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases.
    Harrell CR; Simovic Markovic B; Fellabaum C; Arsenijevic A; Djonov V; Arsenijevic N; Volarevic V
    Adv Exp Med Biol; 2018; 1089():47-57. PubMed ID: 29774506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopreserved Mesenchymal Stromal Cells Maintain Potency in a Retinal Ischemia/Reperfusion Injury Model: Toward an off-the-shelf Therapy.
    Gramlich OW; Burand AJ; Brown AJ; Deutsch RJ; Kuehn MH; Ankrum JA
    Sci Rep; 2016 May; 6():26463. PubMed ID: 27212469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Umbilical Cord Mesenchymal Stem Cells: Subpopulations and Their Difference in Cell Biology and Effects on Retinal Degeneration in RCS Rats.
    Wang L; Li P; Tian Y; Li Z; Lian C; Ou Q; Jin C; Gao F; Xu JY; Wang J; Wang F; Zhang J; Zhang J; Li W; Tian H; Lu L; Xu GT
    Curr Mol Med; 2017; 17(6):421-435. PubMed ID: 29210653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells and potential applications in treating ocular disease.
    Joe AW; Gregory-Evans K
    Curr Eye Res; 2010 Nov; 35(11):941-52. PubMed ID: 20958182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell therapy unable to rescue the vision from advanced Behcet's disease retinal vasculitis: report of three patients.
    Davatchi F; Nikbin B; Shams H; Sadeghi Abdollahi B; Mohyeddin M; Shahram F
    Int J Rheum Dis; 2013 Apr; 16(2):139-47. PubMed ID: 23773637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials.
    Guess AJ; Daneault B; Wang R; Bradbury H; La Perle KMD; Fitch J; Hedrick SL; Hamelberg E; Astbury C; White P; Overolt K; Rangarajan H; Abu-Arja R; Devine SM; Otsuru S; Dominici M; O'Donnell L; Horwitz EM
    Stem Cells Transl Med; 2017 Oct; 6(10):1868-1879. PubMed ID: 28887912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-apoptotic and neuro-protective effects of human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) on acute optic nerve injury is transient.
    Chen M; Xiang Z; Cai J
    Brain Res; 2013 Sep; 1532():63-75. PubMed ID: 23933426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stemming retinal regeneration with pluripotent stem cells.
    Jin ZB; Gao ML; Deng WL; Wu KC; Sugita S; Mandai M; Takahashi M
    Prog Retin Eye Res; 2019 Mar; 69():38-56. PubMed ID: 30419340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model.
    Zwart I; Hill AJ; Al-Allaf F; Shah M; Girdlestone J; Sanusi AB; Mehmet H; Navarrete R; Navarrete C; Jen LS
    Exp Neurol; 2009 Apr; 216(2):439-48. PubMed ID: 19320003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
    Tamaki Y
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.